Skip to main content
Tessa NewsLink
Paste a health news link, or browse

Source study found

Story checked

New technology advances understanding of eye pressure and glaucoma (opens in a new tab)

medicalxpress.com · 2026-10-04

Short answerEvidenceSource

Short answer

Mostly not supported

Mostly not supported.

One key claim is not backed by the study. 2 other points were not covered by the paper.

  • 1 supported
  • 2 overstated
  • 1 not supported
  • 2 not covered

Checked against the study summary. The full text wasn't available, so some details couldn't be settled either way.

Share this check

Follow the evidence trail
1
2

NewsLink checks it

Mostly not supported

Three claims go beyond the study. Two overstate it and one isn't supported at all. Two claims the study doesn't address.

  • 1 supported
  • 2 overstated
  • 1 not supported
  • 2 not covered
Open claim evidence
3
Source paper

Source layer

The 3 papers the story cites

Source study separated from background citations.

The research anchor for the report.

Then inspect each claim

Evidence layer

Claim by claim

Each claim gets a verdict. Expand it to see the evidence directly below.

6 claims in this story

Showing all 6 claimsChoose a verdict to focus the list.

Claim 1 of 6Not supportedWhen the animals were exposed to constant light, the circadian rhythm disappeared and mean pressure started climbing, leading the authors to suggest light may play a larger role in regulating eye pressure than previously understood.View evidenceHide evidence

Why this verdict

The supplied paper profile describes light/dark entrainment, transition to constant darkness for the TTX experiment, and light/dark maintenance after SCGx. It does not describe exposure to constant light, disappearance of rhythm under constant light, or mean IOP climbing under constant light. This claim is not supported by the supplied abstract profile.

Claim 2 of 6OverstatedPassaglia's latest research, published in Investigative Ophthalmology & Visual Science, centers on a first-of-its-kind wireless eye-pressure monitoring system developed in his lab that collects continuous measurements in rats.View evidenceHide evidence

As statedcontinuous measurements in rats

Why this verdict

The supplied profile supports continuous wireless IOP telemetry in adult Brown-Norway rats. It does not verify that the system was 'first-of-its-kind,' developed in Passaglia's lab, or that this was the 'latest' research in Investigative Ophthalmology & Visual Science. The core measurement-method point is supported, but the novelty and provenance framing outrun the paper evidence supplied.

1

Study evidence

Rats exhibit a pronounced circadian IOP rhythm that peaks during subjective night and persists in constant darkness.Baseline 9.5 ± 1.7 mm Hg; peak-to-peak amplitude 4.9 ± 1.4 mm Hg; period 24.0 ± 0.1 h; phase 2.3 ± 1.0 min (values reported as averages in DD before TTX).

“IOP was continuously monitored via wireless telemetry in adult Brown-Norway rats.”
2

Study evidence

Superior cervical ganglionectomy (SCGx) eliminated the day–night difference in IOP: IOP was not significantly different during subjective day versus subjective night after SCGx, indicating loss of the circadian IOP rhythm under LD conditions.

“Another cohort underwent superior cervical ganglionectomy (SCGx) and thereafter was maintained in LD.”
Claim 3 of 6OverstatedUsing the technology, researchers found that eye pressure follows a daily rhythm, rising at night to levels that, if sustained continuously, are associated with glaucoma, even though the animals do not develop the disease for reasons not yet fully understood.View evidenceHide evidence

As statedrising at night to levels associated with glaucoma

Why this verdict

The profile supports that rats showed a pronounced circadian IOP rhythm peaking during subjective night. It does not support the added glaucoma framing: that nighttime levels were equivalent to levels associated with glaucoma if sustained, or that animals do not develop glaucoma for reasons not fully understood. The daily-rhythm finding is supported, but the disease-threshold and animal-disease interpretation are not verified by the abstract profile.

1

Study evidence

Rats exhibit a pronounced circadian IOP rhythm that peaks during subjective night and persists in constant darkness.Baseline 9.5 ± 1.7 mm Hg; peak-to-peak amplitude 4.9 ± 1.4 mm Hg; period 24.0 ± 0.1 h; phase 2.3 ± 1.0 min (values reported as averages in DD before TTX).

“IOP was continuously monitored via wireless telemetry in adult Brown-Norway rats.”
Claim 4 of 6Not coveredA series of three studies led by Christopher Passaglia is helping fill gaps in understanding what regulates daily changes in eye pressure and how those fluctuations may contribute to glaucoma.View evidenceHide evidence

Why this verdict

The abstract-level profile supports that the paper studies regulation of circadian/daily IOP changes in rats and tests neural/sympathetic control. However, it does not verify a 'series of three studies,' Passaglia's leadership, or how the fluctuations contribute to glaucoma. Those broader framing claims are not established by the supplied abstract profile.

1

Study evidence

Rats exhibit a pronounced circadian IOP rhythm that peaks during subjective night and persists in constant darkness.Baseline 9.5 ± 1.7 mm Hg; peak-to-peak amplitude 4.9 ± 1.4 mm Hg; period 24.0 ± 0.1 h; phase 2.3 ± 1.0 min (values reported as averages in DD before TTX).

“IOP was continuously monitored via wireless telemetry in adult Brown-Norway rats.”
2

Study evidence

Superior cervical ganglionectomy (SCGx) eliminated the day–night difference in IOP: IOP was not significantly different during subjective day versus subjective night after SCGx, indicating loss of the circadian IOP rhythm under LD conditions.

“Another cohort underwent superior cervical ganglionectomy (SCGx) and thereafter was maintained in LD.”
Claim 5 of 6Not coveredThe article says the findings are not expected to immediately change glaucoma treatment, but they may help researchers understand why some therapies work differently at different times of day and whether treatment timing could influence effectiveness.View evidenceHide evidence

Why this verdict

The supplied abstract profile is basic in vivo rat research focused on circadian IOP rhythm mechanisms. It does not discuss near-term glaucoma treatment changes, time-of-day variation in therapy effectiveness, or treatment timing. These translational implications may be article-level speculation, but they are not verifiable from the supplied abstract-depth paper profile.

Claim 6 of 6SupportedResearchers also found that the nighttime increase is driven by neural signals traveling from the brain to the eye, suggesting eye pressure is controlled by the body's timing system rather than solely within the eye.View evidenceHide evidence

Why this verdict

This is consistent with the paper profile. Acute neural blockade with TTX suppressed nocturnal IOP elevation, and superior cervical ganglionectomy abolished the day-night IOP difference. The authors interpret these findings as showing that the rat IOP rhythm is driven by sympathetic efferent signals from a central circadian clock rather than local ocular clocks or circulating humoral factors.

1

Study evidence

Rats exhibit a pronounced circadian IOP rhythm that peaks during subjective night and persists in constant darkness.Baseline 9.5 ± 1.7 mm Hg; peak-to-peak amplitude 4.9 ± 1.4 mm Hg; period 24.0 ± 0.1 h; phase 2.3 ± 1.0 min (values reported as averages in DD before TTX).

“IOP was continuously monitored via wireless telemetry in adult Brown-Norway rats.”
2

Study evidence

Superior cervical ganglionectomy (SCGx) eliminated the day–night difference in IOP: IOP was not significantly different during subjective day versus subjective night after SCGx, indicating loss of the circadian IOP rhythm under LD conditions.

“Another cohort underwent superior cervical ganglionectomy (SCGx) and thereafter was maintained in LD.”
Then look for missing context

Context layer

What the story left out

Important study details the story did not include.

  • For the SCGx cohort, the abstract reports only light/dark post-operative conditions and lacks numerical IOP values, variability, sample size, and verification details for denervation.

    The story does not mention that the surgical-denervation evidence was reported under light/dark conditions only, nor the missing quantitative and methodological detail in the abstract.

    From In vivo surgical sympathetic denervation (SCGx) with telemetry IOP monitoring in LD

  • The paper profile supports a mechanistic interpretation about sympathetic efferent signals from a central circadian clock, not direct evidence about glaucoma causation or clinical treatment timing.

    The story includes caveats that the rat work does not immediately change treatment and does not imply everyday artificial light causes glaucoma, but it still adds glaucoma-risk and therapy-timing implications that are not materially supported by the supplied abstract profile.

    From In vivo rat telemetry with unilateral topical TTX under constant darkness; cosinor rhythm analysis; In vivo surgical sym

4 things the story did carry across
  • The paper's central evidence is in vivo rat work using continuous wireless telemetry to measure intraocular pressure rhythms.
  • Rats showed a pronounced circadian IOP rhythm that peaked during subjective night and persisted in constant darkness.
  • Acute topical TTX neural blockade suppressed nocturnal IOP elevation in a phase- and dose-dependent manner, with no effect during subjective day and no effect in the contralateral eye.
  • Superior cervical ganglionectomy eliminated the day-night IOP difference, supporting the necessity of sympathetic efferent signaling for the rhythm.
Then read the study layer

Study layer

Study at a glance

Scan the study first. Expand only the parts you want to inspect.

Pieces of work

2

Evidence read

study summary

Lead result

in vivo animal

1Lead resultin vivo animalTest whether circadian intraocular pressure (IOP) rhythm in rats depends on neural input by acutely blocking ocular neural activity with tetrodotoxin (TTX) during subjective day vs subjective night under constant darkness, using continuous telemetry and circadian rhythm modeling.In vivo rat telemetry with unilateral topical TTX under constant darkness; cosinor rhythm analysisExpand

In plain English

In adult Brown-Norway rats entrained to LD and then held in constant darkness, continuous wireless IOP telemetry plus cosinor modeling showed a persistent circadian IOP rhythm that peaks during subjective night; unilateral topical TTX applied during subjective night (but not subjective day) dose-dependently suppressed the nocturnal IOP elevation (up to 103% ± 15%), with no effect on the non‑instilled contralateral eye and with cosinor parameters (baseline, amplitude, period, phase) reported as unchanged after TTX.

Key findings

  • Rats exhibit a pronounced circadian IOP rhythm that peaks during subjective night and persists in constant darkness.Baseline 9.5 ± 1.7 mm Hg; peak-to-peak amplitude 4.9 ± 1.4 mm Hg; period 24.0 ± 0.1 h; phase 2.3 ± 1.0 min (values reported as averages in DD before TTX).
  • Acute unilateral topical TTX reduced the nocturnal IOP elevation when applied during subjective night but had no effect when applied during subjective day.Dose-dependent reduction of nocturnal elevation by up to 103% ± 15%.
“IOP was continuously monitored via wireless telemetry in adult Brown-Norway rats.”
What this piece can’t prove
  • Abstract does not provide full methodological details on randomization, blinding, or potential systemic effects of topical TTX.

2 further details could not be confirmed from the summary.

2in vivo animalTest whether sympathetic efferent signaling is necessary for the circadian IOP rhythm by eliminating sympathetic input via superior cervical ganglionectomy (SCGx) in rats maintained in light/dark conditions.In vivo surgical sympathetic denervation (SCGx) with telemetry IOP monitoring in LDExpand

In plain English

In adult Brown-Norway rats instrumented with wireless IOP telemetry and maintained in a light/dark cycle, surgical removal of the superior cervical ganglion (SCGx) abolished the day–night (subjective day vs subjective night) difference in intraocular pressure, indicating loss of the circadian IOP rhythm.

Key findings

  • Superior cervical ganglionectomy (SCGx) eliminated the day–night difference in IOP: IOP was not significantly different during subjective day versus subjective night after SCGx, indicating loss of the circadian IOP rhythm under LD conditions.
“Another cohort underwent superior cervical ganglionectomy (SCGx) and thereafter was maintained in LD.”
What this piece can’t prove

3 further details could not be confirmed from the summary.

Finally, the search trail

Method layer

NewsLink found the paper. Tessa takes you deeper.

NewsLink checks the story. Tessa is where you inspect the paper, authors, evidence, and research context.

Papers considered

The selected paper, plus nearby candidates.

PubMed, Europe PMC, Crossref · 35 candidate papers

And 29 more candidates considered.